Description
Composiction:
Each 100 ml of sterile ophthalmic suspension of LOTEOFTAL® contains: Loteprednol etabonate 500 mg
Excipientes: Sulfato de sodio anhidro; Polisorbato 20; Cloruro de sodio; Cloruro de benzalconio; Edetato disódico de calcio; Hidroxipropilmetilcelulosa; Agua para inyectables c.s.
Therapheutic Action:
ATC Code: S01BA14. Anti-inflammatory corticoesteroid.
Indication:
LOTEOFTAL® It is indicated for:
– Treatment of inflammatory ocular conditions of the eyelids and bulbar conjunctiva, cornea, and anterior segment of the eyeball, including allergic conjunctivitis, acne, rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and infectious conjunctivitis in which reducing edema and inflammation is beneficial and where the risks of using corticosteroid agents are justified.
- Treatment of inflammation following ocular surgery.
Presentation: Container containing 5 ml of ophthalmic suspension.